{
    "2021-11-30": [
        [
            {
                "time": "2022-01-10",
                "original_text": "Biotech Penny Stocks to Buy Now",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Penny",
                        "Stocks",
                        "Buy",
                        "Now"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2022-01-10",
                "original_text": "Tests suggest Regeneron antibody treatment for COVID loses effectiveness against omicron variant: WSJ",
                "features": {
                    "keywords": [
                        "Tests",
                        "Regeneron",
                        "antibody",
                        "treatment",
                        "COVID",
                        "loses",
                        "effectiveness",
                        "omicron",
                        "variant",
                        "WSJ"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2022-01-10",
                "original_text": "Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates",
                "features": {
                    "keywords": [
                        "Covid-19",
                        "Antibody",
                        "Drugs",
                        "Challenged",
                        "Omicron",
                        "Preliminary",
                        "Testing",
                        "Indicates"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}